Immunopharmacology in Vernal Keratoconjunctivitis: Current and Future Perspectives

被引:25
作者
Chigbu, DeGaulle, I [1 ]
Labib, Bisant A. [1 ]
机构
[1] Salus Univ, Penn Coll Optometry, 8360 Old York Rd, Elkins Pk, PA 19027 USA
关键词
vernal keratoconjunctivitis; clinicopathologic correlations; immunomodulators; immunobiologics; pharmacotherapy; CYCLOSPORINE-A; 0.05-PERCENT; DRY EYE DISEASE; TOPICAL CYCLOSPORINE; MAST-CELL; ALLERGIC CONJUNCTIVITIS; ATOPIC-DERMATITIS; DENDRITIC CELLS; OCULAR SURFACE; SHIELD ULCERS; CASE SERIES;
D O I
10.3390/ph14070658
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Vernal keratoconjunctivitis (VKC) is a complex and chronic, multifactorial Th2 cell-mediated chronic ocular surface inflammatory condition that typically affects predominantly male children in hot or warm climates. The primary symptom is intense ocular pruritus, often significant enough to affect activities of daily living. Clinical features differ from simple forms of allergic conjunctivitis in that they are more-or-less confined to the superior tarsus and limbus. There is also a risk of corneal involvement, which leads to irreversible vision loss in approximately 6% of patients. Right now, there is no standardized treatment protocol, and many of the currently available options are not effective in severe and recurrent cases. As such, it is imperative to understand this complex allergic immune response in order to identify future therapeutic targets. This review will focus on potential drug targets in VKC, with particular emphasis on immunomodulators and immunobiologic agents.
引用
收藏
页数:22
相关论文
共 217 条
[11]   Omalizumab-induced reductions in mast cell FcεRI expression and function [J].
Beck, LA ;
Marcotte, GV ;
MacGlashan, D ;
Togias, A ;
Saini, S .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (03) :527-530
[12]   CYCLOSPORINE EYEDROPS FOR THE TREATMENT OF SEVERE VERNAL KERATOCONJUNCTIVITIS [J].
BENEZRA, D ;
PEER, J ;
BRODSKY, M ;
COHEN, E .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1986, 101 (03) :278-282
[13]   Atopic Dermatitis and Keratoconjunctivitis [J].
Bielory, Brett ;
Bielory, Leonard .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2010, 30 (03) :323-+
[14]   Allergic and immunologic disorders of the eye. Part II: Ocular allergy [J].
Bielory, L .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (06) :1019-1032
[15]   An algorithm for the management of allergic conjunctivitis [J].
Bielory, Leonard ;
Meltzer, Eli O. ;
Nichols, Kelly K. ;
Melton, Ron ;
Thomas, Randall K. ;
Bartlett, Jimmy D. .
ALLERGY AND ASTHMA PROCEEDINGS, 2013, 34 (05) :408-420
[16]   Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial [J].
Blauvelt, Andrew ;
de Bruin-Weller, Marjolein ;
Gooderham, Melinda ;
Cather, Jennifer C. ;
Weisman, Jamie ;
Pariser, David ;
Simpson, Eric L. ;
Papp, Kim A. ;
Hong, H. Chih-Ho ;
Rubel, Diana ;
Foley, Peter ;
Prens, Errol ;
Griffiths, Christopher E. M. ;
Etoh, Takafumi ;
Pinto, Pedro Herranz ;
Pujol, Ramon M. ;
Szepietowski, Jacek C. ;
Ettler, Karel ;
Kemeny, Lajos ;
Zhu, Xiaoping ;
Akinlade, Bolanle ;
Hultsch, Thomas ;
Mastey, Vera ;
Gadkari, Abhijit ;
Eckert, Laurent ;
Amin, Nikhil ;
Graham, Neil M. H. ;
Pirozzi, Gianluca ;
Stahl, Neil ;
Yancopoulos, George D. ;
Shumel, Brad .
LANCET, 2017, 389 (10086) :2287-2303
[17]   Vernal keratoconjunctivitis [J].
Bonini, S ;
Coassin, M ;
Aronni, S ;
Lambiase, A .
EYE, 2004, 18 (04) :345-351
[18]   EFFECTIVENESS OF NEDOCROMIL SODIUM 2-PERCENT EYEDROPS ON CLINICAL SYMPTOMS AND TEAR FLUID CYTOLOGY OF PATIENTS WITH VERNAL CONJUNCTIVITIS [J].
BONINI, S ;
BARNEY, NP ;
SCHIAVONE, M ;
CENTOFANTI, M ;
BERRUTO, A ;
BONINI, S ;
ALLANSMITH, MR .
EYE, 1992, 6 :648-652
[19]   Vernal keratoconjunctivitis revisited - A case series of 195 patients with long-term follow-up [J].
Bonini, S ;
Bonini, S ;
Lambiase, A ;
Marchi, S ;
Pasqualetti, P ;
Zuccaro, O ;
Rama, P ;
Magrini, L ;
Juhas, T ;
Bucci, MG .
OPHTHALMOLOGY, 2000, 107 (06) :1157-1163
[20]   Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study [J].
Bousquet, J. ;
Devillier, P. ;
Anto, J. M. ;
Bewick, M. ;
Haahtela, T. ;
Arnavielhe, S. ;
Bedbrook, A. ;
Murray, R. ;
van Eerd, M. ;
Fonseca, J. A. ;
Morais Almeida, M. ;
Todo Bom, A. ;
Menditto, E. ;
Passalacqua, G. ;
Stellato, C. ;
Triggiani, M. ;
Ventura, M. T. ;
Vezzani, G. ;
Annesi-Maesano, I. ;
Bourret, R. ;
Bosse, I. ;
Caimmi, D. ;
Cartier, C. ;
Demoly, P. ;
Just, J. ;
Portejoie, F. ;
Siroux, V. ;
Viart, F. ;
Bergmann, K. C. ;
Keil, T. ;
Klimek, L. ;
Moesges, R. ;
Pfaar, O. ;
Shamai, S. ;
Zuberbier, T. ;
Mullol, J. ;
Valero, A. ;
Spranger, O. ;
Tomazic, P. V. ;
Kowalski, M. L. ;
Kuna, P. ;
Kupczyk, M. ;
Raciborski, F. ;
Samolinski, B. ;
Toppila-Salmi, S. K. ;
Valovirta, E. ;
Cruz, A. A. ;
Sarquis-Serpa, F. ;
da Silva, J. ;
Stelmach, R. .
ALLERGY, 2018, 73 (08) :1622-1631